These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS study). Liquemin in Myocardial Infarction During Thrombolysis With Saruplase. Tebbe U; Windeler J; Boesl I; Hoffmann H; Wojcik J; Ashmawy M; Rüdiger Schwarz E; von Loewis P; Rosemeyer P; Hopkins G J Am Coll Cardiol; 1995 Aug; 26(2):365-73. PubMed ID: 7608436 [TBL] [Abstract][Full Text] [Related]
5. Sequential combination thrombolytic therapy for acute myocardial infarction: results of the Pro-Urokinase and t-PA Enhancement of Thrombolysis (PATENT) Trial. Zarich SW; Kowalchuk GJ; Weaver WD; Loscalzo J; Sassower M; Manzo K; Byrnes C; Muller JE; Gurewich V J Am Coll Cardiol; 1995 Aug; 26(2):374-9. PubMed ID: 7608437 [TBL] [Abstract][Full Text] [Related]
6. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group. Zeymer U; Tebbe U; Essen Rv; Haarmann W; Neuhaus KL Am Heart J; 1999 Jan; 137(1):34-8. PubMed ID: 9878934 [TBL] [Abstract][Full Text] [Related]
7. [Thrombolytic therapy in acute myocardial infarct]. Bode C; Baumann H; von Hodenberg E; Kübler W Med Klin (Munich); 1992 Feb; 87(2):64-9. PubMed ID: 1542285 [No Abstract] [Full Text] [Related]
8. New plasminogen activators: a clinical review. Ross AM Clin Cardiol; 1999 Mar; 22(3):165-71. PubMed ID: 10084057 [TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators. Bode C; Smalling RW; Berg G; Burnett C; Lorch G; Kalbfleisch JM; Chernoff R; Christie LG; Feldman RL; Seals AA; Weaver WD Circulation; 1996 Sep; 94(5):891-8. PubMed ID: 8790022 [TBL] [Abstract][Full Text] [Related]
10. Effects of lipoprotein (a) on success rate of thrombolytic therapy in acute myocardial infarction. von Hodenberg E; Kreuzer J; Hautmann M; Nordt T; Kübler W; Bode C Am J Cardiol; 1991 Jun; 67(16):1349-53. PubMed ID: 1828324 [TBL] [Abstract][Full Text] [Related]
11. New developments in thrombolytic therapy. Collen D; Gold HK Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372 [TBL] [Abstract][Full Text] [Related]
12. More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. RAPID Investigators. Smalling RW; Bode C; Kalbfleisch J; Sen S; Limbourg P; Forycki F; Habib G; Feldman R; Hohnloser S; Seals A Circulation; 1995 Jun; 91(11):2725-32. PubMed ID: 7758177 [TBL] [Abstract][Full Text] [Related]